BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31114020)

  • 1. A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
    Kurozumi S; Joseph C; Sonbul S; Alsaeed S; Kariri Y; Aljohani A; Raafat S; Alsaleem M; Ogden A; Johnston SJ; Aleskandarany MA; Fujii T; Shirabe K; Caldas C; Ashankyty I; Dalton L; Ellis IO; Desmedt C; Green AR; Mongan NP; Rakha EA
    Br J Cancer; 2019 Jun; 120(12):1129-1136. PubMed ID: 31114020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.
    Asaoka M; Patnaik SK; Zhang F; Ishikawa T; Takabe K
    Breast Cancer Res Treat; 2020 Jun; 181(2):309-322. PubMed ID: 32285241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.
    Aleskandarany MA; Sonbul S; Surridge R; Mukherjee A; Caldas C; Diez-Rodriguez M; Ashankyty I; Albrahim KI; Elmouna AM; Aneja R; Martin SG; Ellis IO; Green AR; Rakha EA
    Br J Cancer; 2017 Oct; 117(8):1176-1184. PubMed ID: 28829761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.
    Aljohani AI; Toss MS; Green AR; Rakha EA
    Breast Cancer Res Treat; 2023 Apr; 198(3):423-435. PubMed ID: 36418517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer.
    Aleskandarany MA; Sonbul SN; Mukherjee A; Rakha EA
    Pathobiology; 2015 Sep; 82(3-4):113-23. PubMed ID: 26330352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.
    Hamy AS; Lam GT; Laas E; Darrigues L; Balezeau T; Guerin J; Livartowski A; Sadacca B; Pierga JY; Vincent-Salomon A; Coussy F; Becette V; Bonsang-Kitzis H; Rouzier R; Feron JG; Benchimol G; LaƩ M; Reyal F
    Breast Cancer Res Treat; 2018 Jun; 169(2):295-304. PubMed ID: 29374852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast.
    Fidalgo F; Rodrigues TC; Pinilla M; Silva AG; Maciel Mdo S; Rosenberg C; de Andrade VP; Carraro DM; Krepischi AC
    Tumour Biol; 2015 Mar; 36(3):1835-48. PubMed ID: 25391423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of lymph node metastasis in the systemic dissemination of breast cancer.
    Nathanson SD; Kwon D; Kapke A; Alford SH; Chitale D
    Ann Surg Oncol; 2009 Dec; 16(12):3396-405. PubMed ID: 19657697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer.
    Kariri YA; Alsaleem M; Joseph C; Alsaeed S; Aljohani A; Shiino S; Mohammed OJ; Toss MS; Green AR; Rakha EA
    Breast Cancer Res Treat; 2021 Jan; 185(2):293-305. PubMed ID: 33073304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological and prognostic impact of lymphovascular invasion in Colorectal Cancer patients.
    Wang X; Cao Y; Ding M; Liu J; Zuo X; Li H; Fan R
    Int J Med Sci; 2021; 18(7):1721-1729. PubMed ID: 33746588
    [No Abstract]   [Full Text] [Related]  

  • 11. The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.
    Aljohani AI; Toss MS; Kurozumi S; Joseph C; Aleskandarany MA; Miligy IM; Ansari RE; Mongan NP; Ellis IO; Green AR; Rakha EA
    Breast Cancer Res Treat; 2020 Jan; 179(1):79-90. PubMed ID: 31599393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
    Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
    Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of the Detection of Lymphovascular Invasion in Hormone Receptor-Positive Early Breast Cancer in the Era of Molecular Profiling.
    Mutai R; Goldvaser H; Shochat T; Peretz I; Sulkes A; Yerushalmi R
    Oncology; 2019; 96(1):14-24. PubMed ID: 30253418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer.
    Kurozumi S; Joseph C; Sonbul S; Aleskandarany MA; Pigera M; Alsaleem M; Alsaeed S; Kariri Y; Nolan CC; Diez-Rodriguez M; Johnston S; Mongan NP; Fujii T; Shirabe K; Martin SG; Ellis IO; Green AR; Rakha EA
    Breast Cancer Res Treat; 2018 Nov; 172(1):61-68. PubMed ID: 30056565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.
    Joseph C; Macnamara O; Craze M; Russell R; Provenzano E; Nolan CC; Diez-Rodriguez M; Sonbul SN; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Mukherjee A
    Br J Cancer; 2018 Apr; 118(8):1142-1151. PubMed ID: 29588513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
    Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
    Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of lymphovascular invasion in invasive breast carcinoma.
    Rakha EA; Martin S; Lee AH; Morgan D; Pharoah PD; Hodi Z; Macmillan D; Ellis IO
    Cancer; 2012 Aug; 118(15):3670-80. PubMed ID: 22180017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.
    Sonbul SN; Aleskandarany MA; Kurozumi S; Joseph C; Toss MS; Diez-Rodriguez M; Nolan CC; Mukherjee A; Martin S; Caldas C; Ellis IO; Green AR; Rakha EA
    Mod Pathol; 2018 Nov; 31(11):1675-1682. PubMed ID: 29955149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative MRI features associated with lymphovascular invasion in node-negative invasive breast cancer: A propensity-matched analysis.
    Cheon H; Kim HJ; Lee SM; Cho SH; Shin KM; Kim GC; Park JY; Kim WH
    J Magn Reson Imaging; 2017 Oct; 46(4):1037-1044. PubMed ID: 28370761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.